<DOC>
	<DOC>NCT01505426</DOC>
	<brief_summary>To compare the efficacy and safety of ASP1941 + metformin with metformin alone in Asian subjects with type 2 diabetes mellitus.</brief_summary>
	<brief_title>A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diagnosed as type 2 diabetes mellitus patient at least 12 weeks before the study Stable diet and exercise program for at least 8 weeks before the study On a stable dose of at least 1500 mg/day metformin monotherapy or at least 1000 mg/day metformin monotherapy for the subject who can not titrate up to 1500 mg/day due to safety concern of metformin BMI of 20.0 to 45.0 kg/m2 A HbA1c value between 7.0 and 10.0% at screening AND does not meet any of discontinuation criteria on fasting plasma glucose Type 1 diabetes mellitus Proliferative diabetic retinopathy Receiving insulin within 12 weeks prior to the study History of clinically significant renal disease(s) Significant dysuria caused by a neurogenic bladder or a benign prostate hypertrophy etc. Urinary tract infection or genital infection Continuous use of systemic corticosteroids, immunosuppressants, or loop diuretics History of cerebrovascular attack, unstable angina, myocardial infarction, angioplasty, serious cardiac diseases within 12 weeks prior to the study Severe infection, serious trauma, or perioperative subject Known or suspected hypersensitivity to ASP1941 History of treatment with ASP1941 Participated in another clinical study, postmarketing study or medical device study within 12 weeks before the study Serum creatinine value exceeding the upper limit of normal range Urinary microalbumin/urinary creatinine ratio &gt;300 mg/g</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>ipragliflozin</keyword>
	<keyword>metformin</keyword>
	<keyword>plasma glucose</keyword>
	<keyword>urine glucose</keyword>
</DOC>